Joanna Moncrieff

21PUBLICATIONS
42CO-AUTHORS
Child and adolescent developmentTraditional Chinese medicine and treatmentsClinical neuropsychologyPredictive and prognostic markersToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 28, 2026
Concerning the harm-benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval process.

|Nov 19, 2025
Family and informal carers' views and experiences of antipsychotic reduction and discontinuation within a medication reduction research trial.

Sofia Orlando, Maria Long, Johura Akther-Robertson

|Jun 09, 2025
Protocol for the development of a transdiagnostic core outcome set for mental health disorders in adults: the Patient Important Outcomes in Psychiatry (PIO-Psych) Initiative.

Sophie Juul, Pascal Faltermeier, Johanne Juul Petersen

|Apr 14, 2025
The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.

Joanna Moncrieff, Elizabeth Pillai, Louise Marston

|Feb 07, 2025
Beneficial and harmful effects of duloxetine versus placebo, 'active placebo' or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Faiza Siddiqui, Johanne Juul Petersen, Sophie Juul

|Oct 23, 2024
The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.

C B Kamp, J J Petersen, P Faltermeier

Pageof 4

Frequent Collaborators

6 joint publications

Mark Horowitz

5 joint publications

Michael P Hengartner

4 joint publications

Martin Plöderl

3 joint publications

Caroline Kamp Jørgensen